Brennan Davis, APRN
Clinical Nurse Specialist · Jonesboro, ARNPI 1962947200
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 452 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,901, more than ten times the $62 reported in 2021.
Across 452 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$1K
- SK Life Science, Inc.$590
- Pfizer$568
- AstraZeneca$492
- Biogen$367
- plus $3K from 30 others
What the payments were for
- Food & beverage$7,328100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 97 | $1,394 |
| Novartis | 63 | $1,015 |
| SK Life Science, Inc. | 31 | $590 |
| Pfizer | 62 | $568 |
| AstraZeneca(2 entities) | 25 | $492 |
| Biogen | 21 | $367 |
| Amgen | 24 | $355 |
| UCB, Inc. | 11 | $227 |
| Neurelis, Inc. | 10 | $221 |
| Springworks Therapeutics, Inc. | 12 | $217 |
| Eisai Inc. | 9 | $180 |
| Lundbeck LLC | 9 | $176 |
| EMD Serono, Inc. | 9 | $151 |
| Medtronic | 2 | $148 |
| Argenx US, Inc. | 6 | $128 |
| Teva Pharmaceuticals USA, Inc. | 7 | $112 |
| Merz Pharmaceuticals, LLC | 5 | $112 |
| Neurocrine Biosciences, Inc. | 7 | $107 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $88 |
| Lilly USA, LLC | 6 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Amneal Pharmaceuticals LLC | 4 | $77 |
| Impel Pharmaceuticals Inc. | 4 | $64 |
| Alnylam Pharmaceuticals Inc. | 3 | $47 |
| MDD US Operations, LLC | 2 | $45 |
| Kyowa Kirin, Inc. | 2 | $45 |
| Acadia Pharmaceuticals Inc | 2 | $43 |
| Genentech USA, Inc. | 2 | $37 |
| Sanofi | 1 | $37 |
| Averitas Pharma Inc. | 1 | $21 |
| TG Therapeutics, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $16 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| Livanova USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Signia$127
How this compares
Too few clinical nurse specialist providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XcopriCenobamate | 108 | $132,316 |
| Emgality PenGalcanezumab-Gnlm | 160 | $127,693 |
| Nurtec OdtRimegepant Sulfate | 81 | $87,909 |
| UbrelvyUbrogepant | 58 | $75,433 |
| CopaxoneGlatiramer Acetate | 13 | $74,599 |
| QuliptaAtogepant | 74 | $74,225 |
| NuplazidPimavanserin Tartrate | 14 | $70,209 |
| Aimovig AutoinjectorErenumab-Aooe | 52 | $38,215 |
| FycompaPerampanel | 27 | $25,618 |
| ValtocoDiazepam | 14 | $11,359 |
| Pregabalin | 163 | $10,846 |
| OngentysOpicapone | 14 | $8,837 |
| Lacosamide | 37 | $8,071 |
| Levetiracetam | 253 | $6,740 |
| TegretolCarbamazepine | 11 | $6,181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $1,394 | $149,658132 claims |
| SK Life Science, Inc.Xcopri | $590 | $132,316108 claims |
| PfizerNurtec Odt | $568 | $87,90981 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $112 | $74,59913 claims |
| Acadia Pharmaceuticals IncNuplazid | $43 | $70,20914 claims |
| Eisai Inc.Fycompa | $180 | $25,61827 claims |
| Neurelis, Inc.Valtoco | $221 | $11,35914 claims |
| Neurocrine Biosciences, Inc.Ongentys | $107 | $8,83714 claims |
| Upsher-smith Laboratories LLCTopiramate | $16 | $3,279361 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $77 | $1,05911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical nurse specialist providers in Arkansason file to place this against a meaningful peer group, so we don't.
Other clinical nurse specialist in Jonesboro
- Melanie NewJonesboro$10K
- Ashley FeatherstonJonesboro$7K
- Ryan AndersonJonesboro$881
- Deborah FairchildJonesboro$845
- Stephanie McMellonJonesboro$506
- Jessica CampJonesboro$18
- Heather ManchesterFort Smith$6K
- Felicia MayFayetteville$3K
- Tammie SmithGravette$2K
- Dawn SmedleyFayetteville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.